PRESS RELEASE published on 04/08/2024 at 13:00, 1 year 11 months ago 1933 Industries Announces Purchase of 9% Interest of Cultivation and Production Subsidiary 1933 Industries Inc. announces acquisition of membership interests in Alternative Medicine Association LC by its subsidiary, FN Pharmaceuticals, from Company's Executive VP. Purchase price of USD$50,000 to be paid through issuance of common shares Acquisition Common Shares 1933 Industries Inc. FN Pharmaceuticals Alternative Medicine Association LC
BRIEF published on 04/01/2024 at 15:30, 1 year 11 months ago 1933 Industries Reports Q2 2024 Financials with Significant Growth Operational Efficiencies 1933 Industries Cannabis Cultivation Q2 2024 Financials Nevada Cannabis Market
BRIEF published on 04/01/2024 at 15:30, 1 year 11 months ago 1933 Industries publie ses résultats financiers du deuxième trimestre 2024 avec une croissance significative Efficacité Opérationnelle 1933 Industries Culture Du Cannabis Résultats Financiers Du Deuxième Trimestre 2024 Marché Du Cannabis Au Nevada
PRESS RELEASE published on 04/01/2024 at 15:25, 1 year 11 months ago 1933 Industries Reports Q2 2024 Financials 1933 Industries Inc. releases unaudited Q2 2024 financial statements revealing total revenues of $4.74 million, 543% gross profit increase, and strategic measures for increased yield. Company highlights operational efficiencies and net losses Revenues Gross Profit 1933 Industries Inc. Strategic Measures Q2 2024 Financial Statements
BRIEF published on 03/12/2024 at 14:35, 2 years ago 1933 Industries Inc. Announces Suspension of Its CBD Manufacturing Division CBD Market 1933 Industries Inc. Market Demand Canna Hemp™ Cannabis Cultivation
BRIEF published on 03/12/2024 at 14:35, 2 years ago 1933 Industries Inc. annonce la suspension de sa division de fabrication de CBD 1933 Industries Inc. Culture Du Cannabis Marché Du CBD Canna Chanvre™ Demande Du Marché
PRESS RELEASE published on 03/12/2024 at 14:30, 2 years ago 1933 Industries Pauses CBD Manufacturing Division 1933 Industries Inc. announces the suspension of its Canna Hemp™ CBD subsidiary, citing challenges in the CBD market post-COVID. The lack of federal rules and competition are major factors CBD Market 1933 Industries Inc. Canna Hemp™ Suspension Federal Regulations
BRIEF published on 03/02/2024 at 00:05, 2 years ago 1933 Industries Issues Correction on Recent Financial Disclosure Convertible Debenture Financial Disclosure Cannabis 1933 Industries CBD Products
BRIEF published on 03/02/2024 at 00:05, 2 years ago 1933 Industries publie une correction sur la récente divulgation financière Cannabis Divulgation Financière 1933 Industries Débenture Convertible Produits CBD
PRESS RELEASE published on 03/02/2024 at 00:00, 2 years ago 1933 Industries Issues Correction 1933 Industries Inc. corrects the number issued of New 10% Senior Unsecured Convertible Debenture to $3,073,000. The Nevada-based company focuses on cannabis cultivation and manufacturing Cannabis Cultivator 1933 Industries Inc. Senior Unsecured Convertible Debenture Nevada-based Company News Release Correction
Published on 03/26/2026 at 23:00, 38 minutes ago FutureGen Industries Announces Closing of Debt Settlement
Published on 03/26/2026 at 22:05, 1 hour 33 minutes ago BlackBerry to Announce Fourth Quarter and Fiscal Year 2026 Results on April 9, 2026
Published on 03/26/2026 at 22:00, 1 hour 38 minutes ago Clean Air Metals Receives Provincial Funding and Provides Update on the Thunder Bay North Project
Published on 03/26/2026 at 22:00, 1 hour 38 minutes ago Green Bridge Metals Reports Visible Copper Sulfide Mineralization in Initial 2026 Titac Drilling, Duluth Complex Minnesota
Published on 03/26/2026 at 21:00, 2 hours 38 minutes ago Worksport Reports Record FY 2025 Results, Issues $35M–$42M 2026 Revenue Guidance; Targets Initial Cash Flow Positivity
Published on 03/26/2026 at 20:48, 2 hours 49 minutes ago Dermapharm Holding SE repurchases 4,299,190 shares under its public share buyback offer
Published on 03/26/2026 at 19:20, 4 hours 17 minutes ago Critical Path Institute Launches 'One to Millions' to Reshape the Future of Individualized Medicine at Global Scale
Published on 03/26/2026 at 19:09, 4 hours 28 minutes ago 2CRSi SA: Résultats 1er Semestre 2025/26 : Chiffre d'Affaires 204,7 M€ (x9,8) EBITDA de 9,6 M€ (x4,6)
Published on 03/26/2026 at 19:09, 4 hours 28 minutes ago 2CRSi SA: First Half 2025/26 Results: Revenue of €204.7 million (x9.8) EBITDA of €9.6 million (x4.6)
Published on 03/26/2026 at 18:17, 5 hours 21 minutes ago Eiffage se renforce au capital de Getlink et porte sa participation à 29,40 % du capital
Published on 03/26/2026 at 18:17, 5 hours 21 minutes ago Eiffage strengthens its position in Getlink capital
Published on 03/26/2026 at 18:00, 5 hours 38 minutes ago Arrêté des comptes au 31 décembre 2025 et perspectives 2026
Published on 03/26/2026 at 18:00, 5 hours 38 minutes ago LABORATOIRES EUROMEDIS - Fin du contrat de liquidité
